Candida albicans has been shown to vary in its phenotypic expression with the progression of human immunodeficiency virus (HIV) infection. Isolates of C. albicans were obtained from 45 patients with HIV infection during the progression of their disease and differentiated using two methods. The first utilized the morphological characteristics of colonies, and the second method utilized a small portion of C. albicans DNA as a probe on Southern-transferred, EcoRI-digested C. albicans genomic DNA. In 67% of the patients a single strain of C. albicans, as determined by the DNA analysis, was isolated from each individual. The phenotypic expression of the genetically identical strains varied considerably over the experimental period with one morphotype being predominant. These results showed that the genotype of C. albicans persisted in the majority of HIV-infected individuals, but that the phenotypical expression of this strain changed. A novel finding in this study was that 18 strains of C. albicans had DNA which did not hybridize to the probe used. . Candida albicans in patients with the acquired immunodeficiency syndrome : absence of a novel of hypervirulent strain. J Infect Dis 162, 513-518.
INTRODUCTION
The most common fungal disease seen in the oral cavity is candidosis and the Candida species most often involved is C. albicans, although C. glabrata and C. tropicalis are occasionally isolated (MacFarlane, 1990) . Oral candidosis is a common feature of patients with human immunodeficient! virus (HIV) infection. In 17 studies the reported frequent!. of the occurrence of oral candidosis in HIVinfected patients ranged from 11 YO to 96 %, with the majority o f reports quoting frequencies greater than 50 YO (Holmstrup & Samaranayake, 1990) . The frequency of isolation of Candida and clinical signs of oral candidosis have been shown to increase with advancing HIV infection (Torssander e t d., 1987; Korting e t al., 1988) .
Candidosis of the oesophagus is one of the opportunistic infections seen in acquired immunodeficiency syndrome (AIDS) and its presence with HIV infection is diagnostic of AIDS according to the Centers of Disease Control (Atlanta, USA) surveillance definition (Greenspan e t al., 1990) .
It has been postulated that differences in pathogenicity exist between strains of C. albicans and many methods have been developed to divide C. albicans into strains or subpopulations which reflect their pathogenic potential.
These strain-differentiating methods have also been used for epidemiological purposes (Merz, 1990) . Several investigators have suggested that some strains of C. albicans have a greater propensity to cause systemic, nosocomial and superficial infections than d o other strains (Korting e t a/., 1988; Brawner & Cutler, 1989) .
The majority of the strain-differentiating methods are based on the phenotypic characteristics of the organism. One such method is based on the nature and extent of marginal fringing of streak colonies (Phongpaitchit e t al., 1987) . When this method was used by Hunter etal. (1989) on isolates from fatal infections, 67 YO had a discontinuous fringe morphotype whereas this morphotype was seen in only 11 YO of strains isolated from other infections. These authors postulated that there may be an association between virulence and the morphotype of strains of C. alb icans .
Serotyping of C. albicans divides the species into two groups, types A and B (Hasenclever & Mitchell, 1961a) .
Early studies using an animal model (Hasenclever & Mitchell, 1961b ) did not show a correlation between serotype and virulence. More recent studies have shown that there is an increased frequency of 5-fluorocytosine resistance in serotype B (Auger e t al., 1979 ; Brawner e t al., 1992) , and have demonstrated that there is an increased IP: 54.70.40.11
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Recent advances in molecular biology have allowed the use of restriction enzyme analysis of genomic DNA t o classify C. albicans at a subspecies level useful for epidemiological purposes (Magee e t al., 1987 ; Smith t 7 t al., 1989 ; Matthews & Burnie, 1989 ; Monod et al., 1990) . T h e use of a species-specific repeated gene segment as a DNA probe in restriction enzyme analysis has enabled more highly detailed epidemiological studies because of' the large number of different types defined by this technique (Fox e t al., 1989; Scherer & Stevens, 1988) .
T h e aim of the current investigation was t o assess the morphotype, serotype and genotype of oral mucosal candidal organisms in a g r o u p of HIV-infected patients over time t o ascertain if these parameters changed during the experimental period.
Patients. Sixty patients of the Fairfield Hospital for Infectious
Diseases were entered into this study between November 1989 and April 1992 after approval was given by the Erthics Committee of that Hospital. All were diagnosed as group IV HIV infection according to the classification of the Centers for Disease Control (CDC), Atlanta, USA. After receiving informed consent, a complete oral examination was undertaken and oral samples were collected by the imprint culture method of Arendorf & Walker (1980) and the oral rinse technique outlined by Samaranayake e t al. (1986) for laboratory analysis. The patients were reviewed during their normal medical appointments when further oral samples were taken. At each examination the most recent assay of the patients' CD4-positive T lymphocytes as a percentage of total lymphocytes (cells p1-l) was recorded as an indication of immune status. Identification of Candida species. Yeast colonies were speciated by three methods. Firstly, each isolate was assessed for the production of germ tubes after incubation in horse serum at 37 "C in a shaking water bath for 2 h. Secondly, they were assessed for the production of chlamydospores when inoculated under a sterile cover slip in the dark for 72 h on cornmeal agar (Oxoid) containing Tween 80 (Sigma). Finally, each isolate was tested for carbon assimilation by the API 20C AUX identification system (bioMerieux). Samples were separated as either C. albicans or Candida species other than albicans. The C. albzcans samples were serotyped into group A or B by a slide agglutination test using the Iatron factor 6 rabbit antiserum (IF6) (#RM 302-4, Iatron Laboratories). All samples were inoculated into 2 ml of storage medium consisting of 100 ml Luria broth (10 g tryptone, 5 g yeast extract powder, 10 g NaCl in 1 1 sterile deionized water) and 30.5 ml glycerol (BDH Chemicals) and stored at -20 OC until further analysis was performed. Only those patients who had C. albicans isolated on more than one occasion were used in this study.
Colony morphology. For morphotyping, stored yeast cells were resuscitated from -20 OC by culturing on Sabouraud's agar (Oxoid) at 37 OC for 48 h. Single colonies from these cultures were then streaked onto 2 % (w/v) malt agar (Oxoid) and incubated at 30 "C. After 24 h the yeast cells were suspended in sterile deionized water to give a distinct turbidity corresponding to 107-108 cells ml-' as described by Phongpaitchit e t al. (1987) . Agar plates containing 6 % (w/v) malt extract and 2 % (w/v) Difco special agar (Oxoid) were then inoculated with a single diametric streak of the test suspension using a sterile cotton wool swab. Cultures were incubated in the dark for 10 d at 30 "C after which the streak characteristics of each inoculum were determined. A modified three digit coding system of numbers was allocated to the features of the colony streaks as outlined by Hunter e t al. (1989) . The initial digit represents the distribution, the second the width and the third the texture of the fringe. The numbering system for the various attributes is outlined in Table 1 .
Genetic typing. For genetic typing, stored yeast cells were initially cultured on Sabouraud's agar (Oxoid) at 37 "C for 24 h. A single yeast colony from these cultures was then inoculated into 10 ml YPD broth (1 g yeast extract, 2 g bactero-peptone and 2 g D-glucose in 100 ml sterile water) and incubated overnight in a shaking water bath at 37 "C. Candida DNA was prepared by the method of Scherer & Stevens (1987) 
RESULTS
The 60 patients in this study have all died. The average survival time since diagnosis of AIDS (group IV HIV infection, CDC) (Greenspan e t al., 1990) was 20.5 months with a range of 3-36 months.
Forty-five of the 60 patients were included for further analysis on the basis that C. albicans was isolated on more than one occasion during the experimental period. Of the remaining 15 patients, four had C. glabrata, two had C.
kr.u.sei and two had C. tropicalis isolated, four had C. albicans isolated only once and three patients did not have any yeast isolated from their oral cavities during the experimental period. The 45 patients analysed had a total of 295 samples (mean = 6-5 samples per patient) taken at various intervals ranging from 2 to 24 months (mean = 9-3 months). Of these 45 patients, 23 (51 YO) had at some stage during the experimental period signs and symptoms of oral candidosis as diagnosed by the criteria of Greenspan e t al. (1990) . These patients were treated with either amphotericin, nystatin or fluconazole. Twenty of these 23 patients were in a concurrent fluconazole trial which consisted of 100 mg d-' for 1 week and a maintenance dose of 50 mg daily for approximately 2 months. Recurrence of oral candidosis occurred in 48 % (1 1 /23) of digested Candida DNA from consecutive oral isolates. The lanes are grouped above for the same patient and the numbers below are the times in months a t which the isolates were taken. The isolates from patient 9 have two bands a t 3 kb whilst those of patient 10 have one. Two of the isolates from patient 10, 0 and 7 months, did not show any Months 0 1 2 9 10 11 12 17 18 19 0 2 7 9 10 0 1 2 3 hybridization with the DNA probe used. Oral Candida albicans from HIV-infected patients these patients after the medication was ceased. The average time for recurrence was 5-2 months (range 2-9.5 months).
Genetic analysis
Genetic typing of the C. albicans isolates by Southern blot hybridization showed significant variation in the banding patterns between isolates from different patients. This is illustrated in Fig. 1 where the DNA profiles of randomly selected C. albicans isolates from 15 patients are shown. This suggested the existence of a large number of different genetic types within the species which indicated this technique is useful for determining the identity of isolates.
Analyses of all C. albicans isolates by genetic typing revealed that there were 60 genetically different strains isolated from the 45 patients. The majority (30/45) of the patients harboured one strain unique to that patient and this strain persisted over the experimental period (Fig. 2) . Fifteen of the 45 patients (33%) had two genetically different strains isolated during the experimental period.
Of the 149 isolates from these 15 patients, 16 YO (25/149) were genetically different from the predominant strain. In each patient where another strain was isolated, the isolation was not consistently related to episodes of either clinical oral candidosis or antifungal therapy. N o patient had more than two genetically different strains isolated during the experimental period. In 20% (9/45) of patients, 18 of their 74 isolates (24 YO) had genomes which did not show any hybridization with the DNA probe used (Fig. 3) . Each of these strains was regrown on three occasions and the species identification repeated and checked by an independent observer. On each of these three occasions the DNA was extracted before repeating genetic typing as outlined above. All of the 18 strains were shown to be C. albicans whose DNA did not hybridize to the probe (27A) used in this study.
The slide agglutination test for serotyping C. albicans revealed that 88 'YO (53/60) of the genetically different strains isolated were serotype A while the remaining 12 % (7/60) were serotype B.
Mo rp hol og ica I a na I y sis
Each patient examined had two or more C. albicans morphotypes isolated at different times during the study period. The average number of different morphotypes isolated from each patient was 4.6 with a range of between 2 and 11. As an example, the morphotypes shown in Fig.  4 were isolated from the same patient over a 9 month period. From the 45 patients, 37 different morphotypes were isolated. Thirty-seven of the 45 patients (82 %) had the morphotype 754 isolated at least once during the period of examination. This morphotype occurred in 27.5% of all isolates, whereas all other morphotypes occurred at a frequency less than 7 %.
The 295 isolates were divided into groups according to the percentage of CD4-positive T lymphocytes against total lymphocytes (%T4) at the time when each sample was taken. Eighty-three of the 295 isolates (28%) were taken when the %T4 was less than 5 % , while 47% (139/295) were taken when the %T4 was less than 10 %.
x2 analysis of the morphotypes of these groups (%T4 < 5 % , v. %T4 > 5 % ; and %T4 < l o % , v. %T4 > 10%) showed no significance ( P = 0.1 and P = 0.25, respectively) in the occurrence of any one morphotype.
Similarly, when all the discontinuous fringe morphotypes were combined, and the distribution of this combination was compared according to the %T4 of each patient as grouped above, no significant relationship ( P = 0-35 and P = 0.5, respectively) between the discontinuous fringe morphotype and the declining immune status of the patients was found.
DISCUSSION
The rate of multiple isolation of C. albicans from the oral cavity of HIV-infected patients in the present study was 67 % which is similar to that of previous studies (Korting e t al., 1988; Torssander e t al., 1987) . (1992) in their study of HIV seropositive subjects. Such discrepancy may be due to patient selection or degree of immunosuppression of the selected group. In the present study the patients were chosen randomly from individuals regularly attending an out-patient clinic for HIV infection and had been diagnosed as category IV HIV infection (CDC) at the outset of the investigation. In the study of Miyasaki e t al. (1992) , the study group was not separated into any HIV staging classification and thus the degree of immunosuppression of this group was difficult to assess.
Several studies have investigated the genetic relatedness of C. albicans isolates by the use of probes 27A (Fox e t al., 1989) and Ca3 (Sol1 e t al., 1991; Miyasaki e t al., 1992) which represent the same family of repeated sequences (Sadhu e t al., 1991) . The observation of the genetic relatedness of the C. albicans strains from HIV-infected patients reported here differs from those previous studies.
We found that two-thirds of the patients had only one patient-specific strain isolated throughout the course of this study and that one-third had two genetically different strains isolated. This contrasts with the findings of Miyasaki e t al. (1992) who found that none of their 30 patients had more than one strain of C. albicans isolated over the experimental period. Powderly e t al. (1992) also found that by using the same genetic test as described here, all 39 isolates from their HIV-infected patients were a unique genetic type. This research, however, did not assess the temporal presence of C. albicans strains in these patients. Furthermore, Fox e t al. (1989) showed that the DNA profile pattern using the 27A probe was identical in Caugant & Sandven (1993) found that three of their seven patients were colonized by more than one strain. This finding is similar to the results of our study as the number of times a genetically different strain was isolated from the group of patients who harboured two strains in the present study was small (16 YO). The difference between these results may reflect the number of colonies sampled at each time point and the number of oral samples taken from each patient. The second strain may only be present in small numbers in the oral cavity by comparison with the more predominant strain. Throughout this study only one randomly chosen colony was analysed at any one sampling.
The fact that the second, less predominant strain was not consistently isolated during clinical oral lesions, or during treatment with antifungal medication suggested that this strain is not more virulent or more drug resistant. Similar observations have been made in other studies (Miyasaki e t ul., 1992; Whelan e t al., 1990) . Recently, Gallagher e t al.
(1 992) have shown that phenotypically switched variants of C. albicans can develop decreased azole susceptibility even though these strains remained genetically identical. These authors have shown, thereby, that it is not necessary to have alterations in the genetic type of strain for there to be changes in the drug susceptibility of the organism. Blumberg e t al. (1992) provided clinical evidence to support this contention by showing that the same genetic strain of C. albicans was isolated from a patient with fungemia in whom fluconazole failed to eradicate the organism. There was a marked decrease in the in vitro susceptibility of these genetically identical strains throughout the course of this patient's infection.
The lack of hybridization of 18 strains of C. albicans with the species-specific 27A probe has not previously been reported. All of these 18 strains were regrown, speciated independently by the use of the API 20C AUX identification system (bioMerieux). The DNA was exhaustively purified during the extraction procedure before Southern blot hybridization. In each case the strains were C. albicans and their DNA failed to hybridize with the 27A probe. This procedure was repeated on three occasions when the original findings were confirmed. The most likely explanations are that the isolates may be another species of Candidu which are phenotypically identical to C. albicans but genetically distinct, or that the probe target is not present in all strains of C. albicans.
The results of the serotyping of the C. albicans isolates presented here (88 % serotype A and 12 YO serotype B) were similar to the occurrence of serotypes from early studies (Martin & Lamb, 1982) but differed from recent studies of the prevalence of serotype B in the immunocompromised host (Brawner e t al., 1992; Brawner & Cutler, 1989) . In a study comparing different methods of serotyping C. albicans, Brawner (1991) found that the IF6 rabbit antiserum may slant results in favour of type A prevalence by as much as 24% due to autoagglutination of serotype B isolates. This may have increased the prevalence of serotype A in the present study. Reade (1993) found the morphotype 724 to be isolated from 52% of ARC (AIDS-related complex) and AIDS patients, whilst this morphotype was not isolated from HIV asymptomatic patients. These two morphotypes (754 and 724) differ only in the width of the fringe which may reflect technical variations, but both had continuous fine fringes. Oliver & Reade (1992) postulated that there may be an association between progressive immunosuppression from HIV posterity to AIDS and a lack of antibody response to this morphotype and that this change in phenotypic expression may have predictive significance for subsequent disease progression. The findings from the present study showed that morphotype 754 was common in category IV HIV-infected patients, but was not related to their degree of immunosuppression as expressed by the percentage CD4-positive T lymphocytes.
Hunter et al. (1 989) suggested that there was an association between the discontinuous fringe morphotype and fatal deep infections. They made this association by combining the morphotypes with the initial digit 1,2, 3 and 5. When the same combination of morphotypes was made in our study there was no significant relationship with declining immune status. This result supports the theory of Hunter e t al. (1989) that the fringe characteristic is a reflection of anatomical source of the isolate rather than reflecting an association with host immune status. Whether these morphotypes are directly related to any increased virulence of the organism remains unclear and warrants further research. It may be that the changing aorphotypes of genetically identical strains of C. albicans within individuals over time represents switched variants, and in the light of the research by Gallagher e t al. (1992) and Blumberg et al. (1 992) this may have a bearing on changes in the susceptibility of these strains to antifungal agents.
The results of the present study showed that the same genetic strain of oral C. albicans isolated persisted in the majority of category IV HIV-infected individuals, but
